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Abstract
Gastrin-releasing peptide (GRP) has been proposed as a peptidergic molecule for behavioral fear and itching.
Immunohistochemistry and in situ hybridization studies have shown that GRP and GRP receptor are widely distrib-
uted in forebrain areas. Less information is available for the functional action for GRP in the prefrontal cortex
including the anterior cingulate cortex (ACC). Here we used whole-cell patch-clamp recording technique to study
the modulation of synaptic transmission by GRP in the ACC. We found that GRP increased the frequency of sIPSCs
recorded while had no significant effect on sEPSCs in ACC pyramidal neurons. The facilitatory effect of GRP on
sIPSCs was blocked by the GRP receptor antagonist, RC3095. In the presence of TTX, however, GRP had no effect
on the mIPSCs. Therefore, activation of GRP receptor may facilitate the excitation of the interneurons and
enhanced spontaneous GABAergic, but not glutamatergic neurotransmission. Similar results on GRP modulation of
GABAergic transmission were observed in the insular cortex and amygdala, suggesting a general possible effect of
GRP on cortical inhibitory transmission. Our results suggest that GRP receptor is an important regulator of inhibi-
tory circuits in forebrain areas.
Introduction
Gastrin-releasing peptide (GRP) is a mammalian analo-
gue of bombesin (BB), a 14 amino acid-containing pep-
tide first isolated from the skin of the frog Bombina
bombina [1,2]. Anatomic studies have shown that GRP
and its receptors are widely distributed in the central
nervous system, in addition to the gastrointestinal (GI)
tract [2-10]. GRP has been implicated in many physiolo-
gical and pathological conditions such as the regulation
of the circadian rhythm, exocrine and endocrine secre-
tions, smooth muscle contraction, inflammation, feeding,
fear and behavioral itch [11-17].
Recent studies on GRP in sensory systems have trig-
gered new interests on GRP. At the level of the spinal
cord, it has been reported that GRP may serve as a
selective signaling transmitters for itching sensation
[14,15]. In the amygdala, it has been reported that GRP
may contribute to regulation of neuronal excitability,
and contribute to behavioral fear [18]. Although it has
been known that GRP is distributed in cortical areas,
less is known about the possible modulatory effects of
GRP on cortical circuits. The anterior cingulate cortex
(ACC),a key structure of the prefrontal cortex, plays an
established role in learning and memory, drug addiction,
and chronic pain [19-22]. In the present study, we have
investigated the effects of GRP on both excitatory and
inhibitory transmission in the ACC. Our results show
that the GRP selectively facilitate GABAergic but not
glutamatergic neurotransmission. The facilitation may
result from the GRP-induced inward current and firing
of GABAergic interneurons in the ACC.
Methods
Animals
Adult male C57BL/6 mice were purchased from Charles
River (6-10 weeks old). All mice were maintained on a
12 h light/dark cycle with food and water provided ad
libitum. All protocols used were approved by The Ani-
mal Care and use Committee at the University of Tor-
onto and conform to NIH guidelines. * Correspondence: min.zhuo@utoronto.ca
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A d u l tm a l em i c ew e r ea n e s t h e t i z e dw i t h1 - 2 %h a l o t h a n e
and decapitated. Coronal slices (300 μm) containing the
ACC, amygdala or insular cortex will be prepared using
routine methods used in our laboratory [23,24]. Slices
were then transferred to a submerged recovery chamber
with oxygenated (95% O2 and 5% CO2)A C S Fa tr o o m
temperature. After a one-hour recovery period, slices
were placed in a recording chamber on the stage of an
Axioskop 2FS microscope (Zeiss) equipped with infrared
DIC optics for visually-guided whole cell patch clamp
recordings. Pyramidal neurons or interneurons in Layer
II-III in the ACC were recorded with an Axon 200B
amplifier (Molecular device, Union city, CA). Recording
electrodes (2-5 M) contained an internal solution com-
posed of (in mM): Kgluconate, 120; NaCl, 5; MgCl2 1;
EGTA, 0.5; Mg-ATP, 2; Na3GTP, 0.1; HEPES, 10; pH 7.2;
280-300 mOsmol. The membrane potentials were held at
-70 mV throughout all experiments. When recording
GABAA receptor-mediated currents, K-gluconate was
replaced by Cs-MeSO3 and a holding potential of 10 mV.
Spontaneous EPSCs were recorded in the presence of
GABAA receptor antagonist, picrotoxin (100 μM) and
spontaneous IPSCs were recorded in the presence of a
NMDA receptor antagonist, AP5 (100 μM) and a non-
NMDA receptor antagonist, CNQX (20 μM). GRP and
its receptor antagonist RC3095 were purchased from
Sigma. To examine the mIPSCs, TTX (1 μM) was bath-
applied in the perfusion solution. The sIPSCs/mIPSCs
were analyzed with the Mini Analysis Program v5.2.4
(Synaptosoft Inc., Decatur, GA). Access resistance was
15-30MO and monitored throughout the experiments.
Data were discarded if access resistance changed > 15%
during an experiment. Signals were filtered at 1 kHz,
digitized at 10 kHz.
Passive and Active Membrane Properties
Off-line analysis was performed using Clampfit version 9
(Axon Instruments). Resting membrane potential (RMP)
was the low-pass readout of the electrode amplifier and
was not corrected for liquid junction potential (~12 mV)
after terminating the recording. The membrane potential
was measured immediately after establishing the whole-
cell configuration. Only neurons that had a resting mem-
brane potential more negative than -60 mV were further
investigated. Conductance was determined from the lin-
ear slope (between -60 mV to -80 mV) of the current-
voltage (I-V; Vhold = -70 mV) relationships. Action
potentials (APs) were detected in response to suprathres-
hold current injections from a holding potential around
-70 mV. Depolarizing currents of 5~200 pA (400-ms
duration) were delivered in increments of 5 pA until an
Figure 1 Expression of the GRP and GRPR in the ACC (from the Allen Mouse Brain Atlas). (A) In situ hybridization on a coronal section of
mouse brain, showing the expression of the Grp gene in the anterior cingulate cortex (ACC) of wild-type mice (rectangled area http://mouse.
brain-map.org/viewImage.do?imageId=79611383). (B) In situ hybridization on a sagittal section of mouse brain, showing expression of the Grp
receptor gene in ACC of wild-type mice (rectangled area http://mouse.brain-map.org/viewImage.do?imageId=73493204).
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mum current required to evoke an action potential. The
AP voltage threshold (Vthreshold) was defined as the first
point on the rising phase of the spike at which the change
in voltage exceeded 50 mV/ms. The spike amplitude was
quantified as the differen c eb e t w e e nt h eV t h r e s hold and
the peak voltage. The spike width was measured at 1/2 of
t h et o t a ls p i k ea m p l i t u d e( m e a s u r e df r o mt h eV t h r e s hold
level). The amplitude of the afterhyperpolarization (AHP)
was estimated as the difference between the Vthreshold
and the peak of AHP.
Immunohistochemistry
Mice were deeply anesthetized with halothane and per-
fused transcardially with 50-100 ml saline followed by
150-500 ml of cold 0.1 M phosphate buffer (PB) con-
taining 4% paraformaldehyde. Brains were removed and
post-fixed in 4% paraformaldehyde/PBS and then will be
placed in 30% sucrose in 0.2 M PBS, embedded in the
OCT compound and frozen. Coronal sections (30 μM
thickness) were cut using a cryostat. For dual fluores-
cent immunohistochemistry, sections were incubated
overnight with anti-GRPR (1:50; rabbit polycolonal,
Santa Cruz Biotecnology) and anti-GAD67 (1:300;
mouse monoclonal, Chemicon) antibodies at 4°C. Sec-
tions were then be washed 3 times with PBS 0.1 M and
incubated for 2 hours with anti Mouse-FITC and rabbit-
rhodamine conjugated secondary antibodies (1:200; Che-
micon). Images of the ACC areas of at 0.7-μmi n t e r v a l s
with 20× lens were obtained with Bio-Rad Laboratories
MRC 1000 laser-scanning confocal fluorescent imaging
system.
Data Analysis
Results were expressed as mean ± standard error of the
mean (S. E. M.). Statistical comparisons were performed
with the use of one- or two-way analysis of variance
(ANOVA) with the post-hoc Scheffe F-test in immuno-
cytochemical experiments. Analysis of mIPSCs/sEPSCs
was performed with cumulative probability plots and
was compared using the Kolmogorov-Smirnov (K-S) test
for significant differences. In all cases, P < 0.05 was
considered statistically significant.
Results
The expression of GRP and GRP receptors in the ACC
To understand if GRP may be distributed in mouse
ACC, we took the advantage of online brain mapping
data base (the Allen Mouse Brain Atlas). We found that
in adult mouse brains the Grpgene is highly enriched in
the ACC (Figure 1A); http://www.alleninstitute.org),
including the regions of Cg1 and Cg2. Consistent with
Grp distribution in the ACC, the Grp receptors (GRPR)
m R N Aa r ea l s oh i g h l ye x p r e s s e di nt h eA C C( F i g u r e
1B); taken from the Allen Mouse Brain Atlas). To con-
firm the distribution of GRP receptor in the ACC, we
performed double-label immunohistochemistry using
specific antibodies for GRP receptor and GABAergic
neurons (see(Figure 2A and 2B). In addition to the
ACC, we have also examined the regions of the insular
cortex (IC) and basal lateral amygdala (BLA). We found
that GRP receptor was highly expressed in these areas.
Particularly, GRP receptor was co-localized with
Figure 2 GABA immunoreactivity in the GRPR neurons. Double-
immunostaining was performed using anti-GRP-R antibody (in red,
left column) and an antibody specific for GABAergic neurons (anti-
GAD67 antibody, in green center column) in the anterior cingulate
cortex (ACC), basolateral amygdale (BLA) and insular cortex (IC).
A subpopulation of GRP-R immunoreactivity was detected in
GABAergic neurons (arrows), merged in right column. (A) Upper
panels show images from low-powered microscopy. Scale bar = 10
μm. (B) Lower panels show parts of the same sections at higher
magnification. Scale bar = 50 μm.
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Page 3 of 12Figure 3 Morphological and electrophysiological properties of interneurons and pyramidal neurons in the ACC. (A) Representative
coronal section showing the placement of a whole-cell patch recording in a cingulate slice. (B) Diagram representation of the location of the
recorded neurons in layer II/III. (C and D) Photomicrograph of a representative biocytin–labeled layer II/III ACC pyramidal neuron (C) interneuron
(D) as visualized with confocal laser scanning microscopy. (E) Pyramidal neurons showed different firing properties from those observed in
interneurons after current injection (see F). (F) Interneurons were identified by their firing properties. When injected with current step (100 pA
within 400 ms), interneurons showed fast spiking properties. (G and H) current-voltage relationship constructed from values taken at the end of
pulses (dots in E and F).
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Page 4 of 12GAD67, a marker for GABA in some neurons, suggest-
ing GRP receptor is expressed in a subpopulation of
GABAergic interneurons. These results indicate that
GRP may play modulatory roles in these brain areas.
Morphological and electrophysiological properties of
interneurons and pyramidal neurons in the ACC
Since GRP receptor is expressed in many neurons in the
ACC, we wanted to know whether it may function dif-
ferently in different types of neurons, i.e pyramidal neu-
rons and inhibitory interneurons. Next we performed
whole-cell patch-clamp experiments to examine the
effects of GRP on ACC neurons. As previously reported,
we distinguished local inhibitory neurons and pyramidal
neurons morphologically and electrophysiologically
[23,25]. In some experiments, we also performed whole-
cell patch clamp recording combined with biocytin
labeling in ACC neurons (see(Figure 3 for examples).
Typical layer II/III pyramidal cells had a prominent api-
cal dendrite, which ascended toward the superficial
layers, while their basal dendrites were mainly located
within the same layer as the soma (Figure 3C). Somata
of interneurons were usually ovoid in shape and the
soma size was smaller than that of pyramidal cells. In
contrast to the pyramidal cells, interneuron was lack of
the apical dendrite and displayed 2-5 primary dendrites
extending in all directions ((Figure 3D).
Interneurons and pyramidal cells were found to exhi-
bit significantly different input resistances and resting
membrane potentials (see Table 1). In response to a
continuous depolarizing conditions, pyramidal cells
usually fired APs with an rapid initial phase followed by
a slow gradual decline, a phenomenon called “spike fre-
quency adaptation"(Figure 3E), whereas interneurons
fired a regular train of APs (Figure 3F). We also com-
pared the voltage-current relationship (I-V) of pyramidal
neurons and interneurons. The I-V for pyramidal neu-
rons was linear at membrane potentials between -65
and -90 mV, with inward rectification between -90 mV
and -120 mV (Figure 3G), while for interneurons was
linear between -40 mV and -80mV and showed a slight
inward rectification between -100 mV and -120 mV
(Figure 3H). Moreover, we found that interneurons
exhibited a less Rheobase current (interneurons: 56.8 ±
11.8 pA, n = 11; pyramidal neurons: 95.7 ± 7.3 pA,
n =1 1 ,p< 0.01), a lower action potential amplitude
(interneurons: 88.2 ± 2.6 mV, n = 11; pyramidal neu-
rons: 93.8 ± 0.8 mV, n = 11, p< 0.01), a narrower action
potential half-width (interneurons: 1.00 ± 0.05 ms, n =
11; pyramidal neurons: 1.50 ± 0.03 ms, n = 11, p
<0.001) and a bigger after-hyperpolarization (interneur-
ons: -24.8 ± 2.5 mV, n = 11; pyramidal neurons: -6.9 ±
0.3 mV, n = 11, p< 0.001) compared to the pyramidal
cells (see Table 1).
GRP induced inward currents in interneurons but small or
undetectable currents in pyramidal neurons
To examine the function of GRP receptor in the ACC,
GRP was applied through bath solution and the
responses of pyramidal neurons and interneurons were
recorded. At holding potential of -70 mV a short appli-
cation of GRP (300 nM) induced a slowly developing
inward current (peak 16.9 ± 1.8 pA) that recovered
slowly over 10 min (n = 8/10 interneurons). However,
in pyramidal neurons there was undetectable currents
upon GRP application (300 nM, n = 7). In the presence
of GRP receptor antagonist, RC3095 (3 μM), the effect
of GRP induced inward current in interneurons (n = 7)
was completely blocked (data not shown). These results
indicate that GRP selectively activated interneuronal
GRP receptor in the ACC.
Activation of GRP receptors enhances spontaneous
GABAergic, but not glutamatergic transmission
Since GRP can excite interneurons, we speculated that
activation of GRP receptor would affect the release of
GABA in the ACC. To test this idea, we studied the
effect of GRP on GABAergic transmission. At a holding
potential of 10 mV and with the blockade of NMDA
and AMPA/KA current by using AP-5 (50 μM) and
Table 1 Basic electrophysiological properties of ACC pyramidal and inhibitory neurons
Pyramidal Neuron Interneuron Significant Difference
Number of neurons tested 33 18
Resting membrane potential, mV -73.0 ± 1.0 -61.4 ± 1.9 P < 0.001
Input resistance, M Ω 124.3 ± 6.3 332.4 ± 48.1 P < 0.001
Rheobase current, pA 95.7 ± 7.3 56.8 ± 11.8 P < 0.01
Action potential threshold, mV -35.4 ± 0.4 -43.0 ± 0.9 P < 0.001
Action potential amplitude, mV 93.8 ± 0.8 88.2 ± 2.6 P < 0.01
Action potential half-width, ms 1.50 ± 0.03 1.00 ± 0.05 P < 0.001
Amplitude of after-hyperpolarization, ms -6.9 ± 0.3 -24.8 ± 2.5 P < 0.001
Values are Mean ± SEM. Significant differences were obtained by the two-tailed, unpaired student t-test.
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Page 5 of 12Figure 4 Activation of GRP receptor by GRP reversibly increased sIPSCs in pyramidal neurons on the ACC. (A) The representative
example of GRP (300 nM) modulation of sIPSCs in a ACC pyramidal neuron. The trace below represents sIPSCs recorded before, during and after
GRP application. The bottom 3 traces are presented at an expanded scale. (B and C) Time course for the GRP-induced enhancement of sIPSC
frequency and amplitude in the neuron shown in (A). Note the effect of GRP is reversible. (D) Statistical results showed the GRP-induced
enhancement of sIPSC frequency and amplitude in the neuron shown in (A). Note the effect of GRP is reversible. *Indicates a significant
difference between control and GRP. * < 0.05, ** < 0.01. (E) The facilitatory effect of GRP on sIPSC frequency is concentration dependent (30 nM,
n = 6; 300 nM, n = 5; 1000 nM, n = 7). * < 0.05, ** < 0.01, *** < 0.001.
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Page 6 of 12Figure 5 The GRP-induced sIPSC facilitation is blocked by RC3095 and picrotoxin. (A and B) The effect of GRP (300 nM) could be blocked
by RC3095 (3 μM, n = 4), suggesting that the GRP’s action is mediated by GRPR (upper). Representative sIPSCs recorded in a pyramidal cell from
a control mouse at a holding potential of +10 mV under baseline conditions (upper), during GRP application (middle), and after the GRPR
antagonist was added (lower). (C) Time course of reversible drug effect of RC3095 (3 μM) to the enhancement of sIPSC induced by GRP
treatment. (D) The effect of GRP (300 nM) could be blocked by picrotoxin (100 μM, n = 4). Representative sIPSCs recorded in a pyramidal neuron
under baseline conditions (upper), during GRP application (middle), and after picrotoxin was added (lower). (E) Time course of reversible drug
effect of picrotoxin (100 μM) to the enhancement of sIPSC induced by GRP treatment.
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Page 7 of 12CNQX (20 μM), we recorded spontaneous inhibitory
postsynaptic currents (sIPSCs) in pyramidal neurons of
ACC slices from adult mice. GRP (300 nM) increased
both frequency (from 7.0 ± 0.8 Hz to 10.6 ± 1.1 Hz, n =
7, p < 0.001) and amplitude (from 17.1 ± 0.5 pA to 20.3
± 0.6 pA, n = 7, p < 0.05) of sIPSCs (Figure 4A-D). This
facilitation was reversible after the washout of GRP
(Figure 4A-D)). Moreover, the effect of GRP was con-
centration-dependent. The frequency of sIPSCs was sig-
nificantly increased to 140.1 ± 7.8% (n = 10, p < 0.001)
and 183.4 ± 10.6% (n = 10, p <0 . 0 0 1 )a t3 0 0a n d1 0 0 0
nM GRP, respectively (Figure 4E). No significant effect
was observed for 30 nM GRP (100.5 ± 12.4%, n = 5,
p = 0.1, Figure 4E). The mean amplitude of sIPSCs was
also significantly increased at both 300 nM GRP (110.6
±3 . 9 % ,n=5 ,p < 0.05) and 1000 nM GRP (124.8 ±
9.0%, n = 5, p < 0.01) (Figure 4E). To further test
whether the facilitatory effect of sIPSCs by GRP is
mediated by GRP receptor, we applied the selective GRP
receptor antagonist RC3095 following the GRP applica-
tion. We found that RC3095 (3 μM, n = 5) completely
eliminate the enhancement of either frequency or ampli-
tude of sIPSCs in the ACC neurons (Figure 5A-C). The
application of GABAA receptor antagonist picrotoxin
(50 μM) abolished all sIPSCs (Figure 5D-F).
We next tested if glutamatergic neurotransmission in
the ACC was affected by GRP application. At a holding
potential of -70 mV and with the blockade of GABA
current in the presence of picrotoxin (100 μM), we
recorded spontaneous excitatory postsynaptic currents
(sEPSCs) from pyramidal neurons of ACC. We found
that bath application of GRP (300 nM) had no signifi-
cant effect on either the frequency or amplitude of
sEPSCs in ACC pyramidal neurons (n = 5, Figure 6A-B).
Increase of GABA release by GRP is action potential
dependent
To investigate whether GRP receptors are involved in
regulating GABA release in the ACC, we conducted
experiments where RC3095 (3 μM) was applied to the
bath solution after the GRP application. We found that
the facilitatory effect of GRP on sIPSCs was completely
reversed (Figure 7A-C, n = 5), suggesting that the effect
of GRP is mediated by GRPRs. To further confirm these
results, we examined miniaturei n h i b i t o r yp o s t s y n a p t i c
currents (mIPSCs) in the presence of TTX (1 μM). Bath
application of GRP at three different doses (0.03, 0.3
and 3 μM) did not produce any significant effect on
either the frequency or amplitude of mIPSCs (Figure
7D-F). Taken together, these results demonstrate that
effects of GRP were not due to a presynaptic mechan-
ism, but rather associated with depolarization and trig-
gering action-potentials in GABAergic interneurons.
Activation of GRP receptor also increased the frequency
of sIPSCs in pyramidal neurons in the basolateral
anygdala (BLA) and insular cortex (IC)
To examine whether the facilitation of GABAergic
transmission by GRP is a general phenomenon in the
brain, we tested the effect of GRP on inhibitory trans-
mission in the BLA and IC. Similar to the results found
in the ACC, bath application of GRP (300 nM) signifi-
cantly increase the frequency of sIPSCs recorded in pyr-
amidal neurons in the BLA (p < 0.05, n = 8, Figure 8)
and IC (p < 0.05, n = 8, Figure 9). Consistent with the
notion that the facilitatory effects are mediated by the
GRP receptor, these facilitation were completely blocked
by GRP receptor antagonist, RC3095 (3 μM, n = 6;
Figure 8, 9). In the presence of TTX (1 μM), GRP had
no effect on mIPSCs (n = 5; Figure 8 and 9), Moreover,
GRP had no effect on sEPSCs in either BLA or IC
(n = 5, Figure 8 and 9).
Discussion
In the present study, we used whole-cell patch-clamp
recording to study the actions of GRP on ACC neurons
in adult mice. Our results provide strong electrophysiolo-
gical evidence that GRP receptor facilitates inhibitory
Figure 6 Activation of GRP receptor by GRP had no effect on sEPSCs in pyramidal neurons of ACC. (A) Typical traces showing the effect
of GRP (300 nM) on sEPSCs in a pyramidal neuron. (B) Statistical results showed no effect of GRP on either frequency or amplitude of sEPSCs in
pyramidal neurons (n = 6).
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Page 8 of 12Figure 7 Increase of GABA release by GRP is action potential dependent. (A) The effect of GRP (300 nM) could be blocked by TTX (1 μM,
n = 4). (B) Representative sIPSCs recorded in a pyramidal neuron under baseline conditions (upper), during GRP application (middle), and after
TTX was added (lower). (C) Time course of reversible drug effect of TTX (1 μM) to the enhancement of sIPSC induced by GRP treatment. (D and
E) Typical examples showing the effect of GRP (300 nM) on mIPSCs in the presence of TTX. Similar results were obtained from an additional 4
neurons. (F) Statistical results showed in the presence of TTX (1 μM), GRP did not affect either amplitude or frequency of mIPSCs.
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Page 9 of 12GABA release in the ACC. Activation of GRP receptor
preferentially modulated GABAergic, but not glutamater-
gic transmission. Furthermore, somatodendritic GRP
receptor mediated action potential-dependent GABA
release in the ACC occurred in other regions, such as the
BLA and IC, indicating a general role of GRP receptor in
the modulation of cortical GABAergic transmission.
How GRP facilitate GABAergic transmission and modu-
late the neuronal circuits in the ACC? Several lines of evi-
dence in the present study suggest that GRP acts on
somatodendritic GRP receptor in GABAergic neurons to
induce neuronal firing and GABA release in interneurons,
thereby decreasing the excitability of pyramidal neurons.
Bath application of GRP facilitated sIPSC frequency in a
Figure 8 Activation of GRP receptors increased GABA release in BLA neurons. (A) Bath application of GRP (300 nM) increased the
frequency of sIPSCs in pyramidal neurons of BLA (n = 11). (B) The effect of GRP was completely blocked by RC 3091 (3 μM) (n = 5). (C) No
increase of the frequency of sIPSCs was observed in the presence of TTX (1 μM) (n = 5). (D) There is no effect of GRP on sEPSCs (n = 4). Holding
potential for recording sEPSCs was -70 mV.
Figure 9 Activation of GRP receptors increased GABA release in IC neurons. (A and B) Bath application of GRP (300 nM) increased the
frequency of sIPSCs in pyramidal neurons of IC (n = 11). (B) The effect of GRP was completely blocked by RC 3091 (3 μM) (n = 5). (C) However,
no increase was observed in the presence of TTX (1 μM) (n = 5). (D) There is no effect of GRP on sEPSCs (n = 4). Holding potential for recording
sEPSCs was -70 mV.
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Page 10 of 12concentration- dependent manner, but GRP had little
effect on either frequency or amplitude of mIPSCs. These
results are similar to the modulatory effects of the GRP/
GRP receptor system on GABAergic transmission in lat-
eral amygdala and hippocampus [18,26]. Interestingly, in
the present study, although ACC pyramidal neurons are
shown to express GRP receptors, we found little direct
effect of GRP on these cell bodies nor on the frequency
and amplitude of sEPSC. We cannot completely rule out
other possible modulation of GRP on excitatory transmis-
sion that cannot be revealed in the present studies. Future
studies are clearly needed in further investigating the roles
of GRP.
ACC neurons are multi-functional and play important
roles in a wide variety of behavioral functions, including
sensory pain, memory, emotional and cognitive func-
tions [19-22,27,28]. Glutamate is the fast excitatory
transmitter [29] and GABA is the inhibitory transmitter
in the ACC [30]. A balance between excitatory and inhi-
bitory transmission is critical for many brain functions.
Previous reports show that the GRP in the amygdala is
inovolved in behavioral fear [18,31-36]. In addition to
the amygdala, recent studies show that lesion of the
ACC produced an impairment in trace fear conditioning
[37] and electrical stimulation of the ACC induced fear
memory [38]. The results of the present study show that
GRP may facilitate the GABAergic transmission in the
ACC synapses, indicating that GRP may contribute to
behavioral fear or trace fear memory by affecting inhibi-
tory transmission within the ACC.
GRP has been implicated in mediation the itch sensa-
tion in the spinal cord [14,15]. The possible roles of
GRP within the ACC in behavioral itching have not
been investigated. Furthermore, a recent work in the
spinal dorsal horn suggests that alteration of inhibitory
transmission in the spinal cord is important for beha-
vioral itching [39]. It is possible that GRP may also
affect spinal inhibitory transmission, in addition to act
as a potential transmitter for itch from the periphery.
Future studies are clearly needed in the spinal cord.
Furthermore, direct evidence for GRP to act as a neu-
rotransmitter for itching is still lacking. In human stu-
dies, ACC and IC have been shown to be involved in
itch processing [40-45]. Future studies are required to
address whether the modulation of GRP in the ACC
inhibitory circuit would contribution to itch sensation.
In summary, we report here that GRP play an impor-
tant role in modulating inhibitory transmission within
the ACC, IC and amygdala. It is likely that supraspinal
GRP may contribute to a wide range of physiological
and pathological functions, rather than act as a selec-
tive transmitter for itch as reported at the level of
spinal cord.
Conflict of interests
The authors declare that they have no competing interests.
Authors’ contributions
XYC, VM, PL and LJW performed the experiments included in the
manuscript. MZ designed the experiments. XYC, LJW and MZ wrote the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by Grants from the EJLB-CIHR Michael Smith Chair
in Neurosciences and Mental Health, Canada Research Chair, NeuroCanada,
and CIHR operating grants (CIHR66975 and CIHR81086) (M. Z.). M.Z. is also
supported by the World-Class University (WCU) program of the Ministry of
Education, Science and Technology in Korea through KOSEF (R32-10142).
Author details
1Department of Physiology, Faculty of Medicine, University of Toronto, 1
King’s College Circle, Toronto, Ontario M5S 1A8, Canada.
2Department of
Brain and Cognitive Sciences, College of Natural Sciences, Seoul National
University, Seoul 151-746, Korea.
Received: 23 July 2010 Accepted: 13 September 2010
Published: 13 September 2010
References
1. Anastasi A, Erspamer V, Bucci M: Isolation and structure of bombesin and
alytesin, 2 analogous active peptides from the skin of the European
amphibians Bombina and Alytes. Experientia 1971, 27(2):166-167.
2. Battey J, Wada E: Two distinct receptor subtypes for mammalian
bombesin-like peptides. Trends Neurosci 1991, 14(12):524-528.
3. Kamichi S, Wada E, Aoki S, Sekiguchi M, Kimura I, Wada K:
Immunohistochemical localization of gastrin-releasing peptide receptor
in the mouse brain. Brain Res 2005, 1032(1-2):162-170.
4. Ladenheim EE, Jensen RT, Mantey SA, Moran TH: Distinct distributions of
two bombesin receptor subtypes in the rat central nervous system. Brain
Res 1992, 593(2):168-178.
5. Moody TW, Getz R, O’Donohue TL, Rosenstein JM: Localization of
receptors for bombesin-like peptides in the rat brain. Ann N Y Acad Sci
1988, 547:114-130.
6. Moody TW, O’Donohue TL, Jacobowitz DM: Biochemical localization and
characterization of bombesin-like peptides in discrete regions of rat
brain. Peptides 1981, 2(1):75-79.
7. Moran TH, Moody TW, Hostetler AM, Robinson PH, Goldrich M, McHugh PR:
Distribution of bombesin binding sites in the rat gastrointestinal tract.
Peptides 1988, 9(3):643-649.
8. Panula P, Yang HY, Costa E: Neuronal location of the bombesin-like
immunoreactivity in the central nervous system of the rat. Regul Pept
1982, 4(5):275-283.
9. Wada E, Way J, Lebacq-Verheyden AM, Battey JF: Neuromedin B and
gastrin-releasing peptide mRNAs are differentially distributed in the rat
nervous system. J Neurosci 1990, 10(9):2917-2930.
10. Wada E, Way J, Shapira H, Kusano K, Lebacq-Verheyden AM, Coy D,
Jensen R, Battery J: cDNA cloning, characterization, and brain region-
specific expression of a neuromedin-B-preferring bombesin receptor.
Neuron 1991, 6(3):421-430.
11. Gamble KL, Allen GC, Zhou T, McMahon DG: Gastrin-releasing peptide
mediates light-like resetting of the suprachiasmatic nucleus circadian
pacemaker through cAMP response element-binding protein and Per1
activation. J Neurosci 2007, 27(44):12078-12087.
12. Petronilho F, Roesler R, Schwartsmann G, Dal Pizzol F: Gastrin-releasing
peptide receptor as a molecular target for inflammatory diseases.
Inflamm Allergy Drug Targets 2007, 6(4):197-200.
13. Patel O, Shulkes A, Baldwin GS: Gastrin-releasing peptide and cancer.
Biochim Biophys Acta 2006, 1766(1):23-41.
14. Sun YG, Chen ZF: A gastrin-releasing peptide receptor mediates the itch
sensation in the spinal cord. Nature 2007, 448(7154):700-703.
15. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF: Cellular basis of itch
sensation. Science 2009, 325(5947):1531-1534.
16. Gonzalez N, Moody TW, Igarashi H, Ito T, Jensen RT: Bombesin-related
peptides and their receptors: recent advances in their role in physiology
and disease states. Curr Opin Endocrinol Diabetes Obes 2008, 15(1):58-64.
Cao et al. Molecular Pain 2010, 6:52
http://www.molecularpain.com/content/6/1/52
Page 11 of 1217. Ohki-Hamazaki H, Iwabuchi M, Maekawa F: Development and function of
bombesin-like peptides and their receptors. Int J Dev Biol 2005, 49(2-
3):293-300.
18. Shumyatsky GP, Tsvetkov E, Malleret G, Vronskaya S, Hatton M, Hampton L,
Battey JF, Dulac C, Kandel ER, Bolshakov VY: Identification of a signaling
network in lateral nucleus of amygdala important for inhibiting memory
specifically related to learned fear. Cell 2002, 111(6):905-918.
19. Courtney SM, Petit L, Maisog JM, Ungerleider LG, Haxby JV: An area
specialized for spatial working memory in human frontal cortex. Science
1998, 279(5355):1347-1351.
20. Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC: Pain affect
encoded in human anterior cingulate but not somatosensory cortex.
Science 1997, 277(5328):968-971.
21. Zhao MG, Toyoda H, Lee YS, Wu LJ, Ko SW, Zhang XH, Jia Y, Shum F, Xu H,
Li BM, et al: Roles of NMDA NR2B subtype receptor in prefrontal long-
term potentiation and contextual fear memory. Neuron 2005,
47(6):859-872.
22. Zhuo M: Glutamate receptors and persistent pain: targeting forebrain
NR2B subunits. Drug Discov Today 2002, 7(4):259-267.
23. Cao XY, Xu H, Wu LJ, Li XY, Chen T, Zhuo M: Characterization of intrinsic
properties of cingulate pyramidal neurons in adult mice after nerve
injury. Mol Pain 2009, 5-73.
24. Wu LJ, Ko SW, Toyoda H, Zhao MG, Xu H, Vadakkan KI, Ren M, Knifed E,
Shum F, Quan J, et al: Increased anxiety-like behavior and enhanced
synaptic efficacy in the amygdala of GluR5 knockout mice. PLoS One
2007, 2(1):e167.
25. Wu LJ, Toyoda H, Zhao MG, Lee YS, Tang J, Ko SW, Jia YH, Shum FW,
Zerbinatti CV, Bu G, et al: Upregulation of forebrain NMDA NR2B
receptors contributes to behavioral sensitization after inflammation. J
Neurosci 2005, 25(48):11107-11116.
26. Lee K, Dixon AK, Gonzalez I, Stevens EB, McNulty S, Oles R, Richardson PJ,
Pinnock RD, Singh L: Bombesin-like peptides depolarize rat hippocampal
interneurones through interaction with subtype 2 bombesin receptors. J
Physiol 1999, 518(Pt 3):791-802.
27. Zhuo M: Cortical excitation and chronic pain. Trends Neurosci 2008,
31(4):199-207.
28. Zhuo M: A synaptic model for pain: long-term potentiation in the
anterior cingulate cortex. Mol Cells 2007, 23(3):259-271.
29. Wei F, Li P, Zhuo M: Loss of synaptic depression in mammalian anterior
cingulate cortex after amputation. J Neurosci 1999, 19(21):9346-9354.
30. Wu LJ, Xu H, Ren M, Zhuo M: Genetic and pharmacological studies of
GluR5 modulation of inhibitory synaptic transmission in the anterior
cingulate cortex of adult mice. Dev Neurobiol 2007, 67(2):146-157.
31. Yamada K, Santo-Yamada Y, Wada E, Wada K: Role of bombesin (BN)-like
peptides/receptors in emotional behavior by comparison of three strains
of BN-like peptide receptor knockout mice. Mol Psychiatry 2002,
7(1):113-117, 116.
32. Martins MR, Reinke A, Valvassori SS, Machado RA, Quevedo J,
Schwartsmann G, Roesler R: Non-associative learning and anxiety in rats
treated with a single systemic administration of the gastrin-releasing
peptide receptor antagonist RC-3095. Peptides 2005, 26(12):2525-2529.
33. Roesler R, Kopschina MI, Rosa RM, Henriques JA, Souza DO,
Schwartsmann G: RC-3095, a bombesin/gastrin-releasing peptide
receptor antagonist, impairs aversive but not recognition memory in
rats. Eur J Pharmacol 2004, 486(1):35-41.
34. Roesler R, Meller CA, Kopschina MI, Souza DO, Henriques JA,
Schwartsmann G: Intrahippocampal infusion of the bombesin/gastrin-
releasing peptide antagonist RC-3095 impairs inhibitory
avoidanceretention. Peptides 2003, 24(7):1069-1074.
35. Santo-Yamada Y, Yamada K, Wada E, Goto Y, Wada K: Blockade of
bombesin-like peptide receptors impairs inhibitory avoidance learning
in mice. Neurosci Lett 2003, 340(1):65-68.
36. Venturella R, Lessa D, Luft T, Roozendaal B, Schwartsmann G, Roesler R:
Dexamethasone reverses the memory impairment induced by
antagonism of hippocampal gastrin-releasing peptide receptors. Peptides
2005, 26(5):821-825.
37. Han CJ, O’Tuathaigh CM, van Trigt L, Quinn JJ, Fanselow MS, Mongeau R,
Koch C, Anderson DJ: Trace but not delay fear conditioning requires
attention and the anterior cingulate cortex. Proc Natl Acad Sci USA 2003,
100(22):13087-13092.
38. Tang J, Ko S, Ding HK, Qiu CS, Calejesan AA, Zhuo M: Pavlovian fear
memory induced by activation in the anterior cingulate cortex. Mol Pain
2005, 1:6.
39. Ross SE, Mardinly AR, McCord AE, Zurawski J, Cohen S, Jung C, Hu L,
Mok SI, Shah A, Savner EM, et al: Loss of inhibitory interneurons in the
dorsal spinal cord and elevated itch in Bhlhb5 mutant mice. Neuron
65(6):886-898.
40. Darsow U, Drzezga A, Frisch M, Munz F, Weilke F, Bartenstein P,
Schwaiger M, Ring J: Processing of histamine-induced itch in the human
cerebral cortex: a correlation analysis with dermal reactions. J Invest
Dermatol 2000, 115(6):1029-1033.
41. Drzezga A, Darsow U, Treede RD, Siebner H, Frisch M, Munz F, Weilke F,
Ring J, Schwaiger M, Bartenstein P: Central activation by histamine-
induced itch: analogies to pain processing: a correlational analysis of
O-15 H2O positron emission tomography studies. Pain 2001,
92(1-2):295-305.
42. Herde L, Forster C, Strupf M, Handwerker HO: Itch induced by a novel
method leads to limbic deactivations a functional MRI study. J
Neurophysiol 2007, 98(4):2347-2356.
43. Mochizuki H, Sadato N, Saito DN, Toyoda H, Tashiro M, Okamura N, Yanai K:
Neural correlates of perceptual difference between itching and pain: a
human fMRI study. Neuroimage 2007, 36(3):706-717.
44. Mochizuki H, Tashiro M, Kano M, Sakurada Y, Itoh M, Yanai K: Imaging of
central itch modulation in the human brain using positron emission
tomography. Pain 2003, 105(1-2):339-346.
45. Valet M, Pfab F, Sprenger T, Woller A, Zimmer C, Behrendt H, Ring J,
Darsow U, Tolle TR: Cerebral processing of histamine-induced itch using
short-term alternating temperature modulation–an FMRI study. J Invest
Dermatol 2008, 128(2):426-433.
doi:10.1186/1744-8069-6-52
Cite this article as: Cao et al.: Facilitation of the inhibitory transmission
by gastrin-releasing peptide in the anterior cingulate cortex. Molecular
Pain 2010 6:52.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Cao et al. Molecular Pain 2010, 6:52
http://www.molecularpain.com/content/6/1/52
Page 12 of 12